Indexing and Global Visibility
Ensuring your research makes a definitive impact across the clinical and academic world.
Maximizing Research Discoverability
We ensure that every article published in Journal of Hematology and Oncology Research is discoverable by oncologists and scientists worldwide.
Our strategic partnerships bridge the gap between discovery and patient-care innovation.
For research in hematology and oncology, visibility is a pathway to clinical advancement. When a manuscript is indexed in global repositories, it becomes part of the shared record of human health, accessible to researchers developing the next generation of therapies. Journal of Hematology and Oncology Research (JHOR) prioritizes aggressive indexing to ensure your findings are integrated into the global scientific dialogue.
ISSN (Online)
Uniquely identified for international serial lookup and standardized library cataloging.
DRJI
Indexed in the Directory of Research Journals Indexing for broad multidisciplinary exposure.
ResearchBib
Included in a premier academic database tracking impact and scholarly engagement.
IPIndexing
Recognized for scholarly quality and clinical research credibility across global territories.
Search engine indexing ensures JHOR articles appear at the top of relevant results for modern clinicians.
- Google Scholar
- Semantic Scholar
- Open Access Library (OALib)
- Monitoring Mast Cell Populations in Waldenström’s Macroglobulinemia
- Molecular Cytogenetic Investigations: Pediatric B-ALL Case
We facilitate the presence of JHOR research on leading scholarly platforms for peer discussion and citation.
- Academia.edu
- ResearchGate
- Lafayette Digital Repository
- Blood Donation and Misconceptions
- Update on Hemocytes in Biomphalaria Snails
- Monoclonal Gammopathy and Philadelphia Chromosome
JHOR is visible across specialized tools used for evidence-based medicine and citation analysis.
- Scite
- Colab
- Amanote Research
- R Discovery by Editage
- Targeting Cell Metabolism in Chronic Lymphocytic Leukaemia
- Plerixafor Efficacy in Autologous Peripheral Blood Stem Cells
- Cholesterol-Conjugated siRNA in Hematopoietic Cells
Join the Scientific Dialogue
Submit your research to a journal that prioritizes clinical impact and global reach.
Advancing cancer care through transparent publishing. Last updated: January 2026.